The practical takeaway If your physician cites animal studies as the primary reason to avoid GLP-1 therapy while breastfeeding, ask about the human lactation data that has since been published
Ipamorelin's binding profile at GHS-R1a appears to produce a more restricted downstream signaling pattern
Argueta DA, Ventura CM, Kiven S, Sagi V, Gupta K
Multipathway disease modulation By activating Nrf2 and interconnected pathways, they concurrently suppress pro-inflammatory signaling (e.g., NF-B), reduce apoptotic susceptibility, and improve metabolic efficiency via PGC-1 regulation
Research in healthy volunteers revealed that a single dose of ipamorelin at 100mcg/kg body weight significantly raised GH, with peaks reaching around 80mIU/l (approximately 26.6ng/ml)